BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2 AND Treatment
6 results:

  • 1. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication.
    Sheng X; Dai H; Du Y; Peng J; Sha R; Yang F; Zhou L; Lin Y; Xu S; Wu Y; Yin W; Lu J
    J Exp Clin Cancer Res; 2021 Jun; 40(1):205. PubMed ID: 34162418
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
    Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
    Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Benefits of Metformin Use for Cholangiocarcinoma.
    Kaewpitoon SJ; Loyd RA; Rujirakul R; Panpimanmas S; Matrakool L; Tongtawee T; Kootanavanichpong N; Kompor P; Chavengkun W; Kujapun J; Norkaew J; Ponphimai S; Padchasuwan N; Pholsripradit P; Eksanti T; Phatisena T; Kaewpitoon N
    Asian Pac J Cancer Prev; 2015; 16(18):8079-83. PubMed ID: 26745042
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
    Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
    J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Response to second line chemo-endocrine treatment may prolong the overall survival of advanced breast cancer patients.
    Nomura Y
    Anticancer Res; 1997; 17(2B):1425-30. PubMed ID: 9137509
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.